Oxygenated Scaffolds for Pancreatic Endocrine Differentiation from Induced Pluripotent Stem Cells
- PMID: 37885129
- PMCID: PMC11578060
- DOI: 10.1002/adhm.202302275
Oxygenated Scaffolds for Pancreatic Endocrine Differentiation from Induced Pluripotent Stem Cells
Abstract
A 3D microenvironment is known to endorse pancreatic islet development from human induced pluripotent stem cells (iPSCs). However, oxygen supply becomes a limiting factor in a scaffold culture. In this study, oxygen-releasing biomaterials are fabricated and an oxygenated scaffold culture platform is developed to offer a better oxygen supply during 3D iPSC pancreatic differentiation. It is found that the oxygenation does not alter the scaffold's mechanical properties. The in situ oxygenation improves oxygen tension within the scaffolds. The unique 3D differentiation system enables the generation of islet organoids with enhanced expression of islet signature genes and proteins. Additionally, it is discovered that the oxygenation at the early stage of differentiation has more profound impacts on islet development from iPSCs. More C-peptide+ /MAFA+ β and glucagon+ /MAFB+ α cells formed in the iPSC-derived islet organoids generated under oxygenated conditions, suggesting enhanced maturation of the organoids. Furthermore, the oxygenated 3D cultures improve islet organoids' sensitivity to glucose for insulin secretion. It is herein demonstrated that the oxygenated scaffold culture empowers iPSC islet differentiation to generate clinically relevant tissues for diabetes research and treatment.
Keywords: in-situ oxygenation; induced pluripotent stem cells; insulin; islet organoids; pancreatic differentiation.
© 2023 Wiley-VCH GmbH.
Conflict of interest statement
Conflict of Interest
The authors declare no conflict of interest.
Figures








References
-
- AdvisoryBoard, https://www.advisory.com/daily-briefing/2017/01/30/diabetes-2 (accessed: January 2017).
-
- Jin S, Stem Cell Res J. Transp. 2014, 1, 4.
-
- Bi H, Ye K, Jin S, Biomaterials 2020, 233, 119673; - PubMed
- Karanth SS, Sun S, Bi H, Ye K, Jin S, Sci. Rep. 2021, 11, 13558; - PMC - PubMed
- Pagliuca FW, Millman JR, Gürtler M, Segel M, Van Dervort A, Ryu JH, Peterson QP, Greiner D, Melton DA, Cell 2014, 159, 428; - PMC - PubMed
- Rezania A, Bruin JE, Arora P, Rubin A, Batushansky I, Asadi A, O’dwyer S, Quiskamp N, Mojibian M, Albrecht T, Yang YHC, Johnson JD, Kieffer TJ, Nat. Biotechnol. 2014, 32, 1121; - PubMed
- Yefroyev DA, Jin S, Biomedicines 2022, 10, 208; - PMC - PubMed
- Ogi DA, Jin S, Cells 2023, 12, 1442. - PMC - PubMed
-
- Walczak MP, Drozd AM, Stoczynska-Fidelus E, Rieske P, Grzela DP, J. Transl. Med. 2016, 14, 341; - PMC - PubMed
- Akinci E, Banga A, Greder LV, Dutton JR, Slack JMW, Biochem. J. 2012, 442, 539; - PMC - PubMed
- Bernardo AS, Cho CH-H, Mason S, Docherty HM, Pedersen RA, Vallier L, Docherty K, Stem Cells 2009, 27, 341. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources